Cirrus Earplugs Looks To OTC Sleep Aids For Partnership
This article was originally published in The Tan Sheet
Executive Summary
After becoming the leading seller of brand and private-label earplugs, Cirrus Healthcare Products’ further growth depends on expanding the market for its products. CEO Drew O’Connell says he is talking with OTC firms about co-marketing products, with OTC sleep aids as good potential candidates.
You may also be interested in...
P&G Launches ZzzQuil To Enter OTC Sleep Aid Category
While other national brand names compete in the OTC sleep aid tablet category, P&G’s NyQuil line extension is by far the biggest name among current players in the liquid product category, which has annual growth of nearly 80%.
FDA Warns Matrixx On Combination Supplement/Drug Products
Matrixx Initiatives’ troubled history with FDA continues with a warning two of its products are unapproved new drugs because they combine supplements with OTC drugs.
Jurors' Answers In FTC Complaint Against Prevagen Might Form A Memory Bubble For Health Claims
“No” answers in New York federal court on whether all but two of Prevagen claims were “materially misleading” could put a fork in the road of a long dispute between FTC and supplement product manufacturers and marketers.